•  
  •  
  •  
  •  

2023-12-05 07:21:54

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • ReNew Signs MoU with Asian Development Bank for US$ 5.3 billion
  • Shree Ajit Pulp and Paper Ltd resumes production process at Unit I
  • Techknowgreen Solutions Ltd receives order worth Rs. 18 crores
  • Quess and NSDC Sign MoU to Enhance Skill Development and Employability
  • Tata Elxsi recognized as India's Top Value Creator for Software and BPM by Dun & Bradstreet

Keywords Selected:  USFDA

Stock Report

  • Granules India Limited Received ANDA Approval for Sildenafil for Oral Suspension
  • Alkem Laboratories Ltd receives 3 observations from USFDA for API manufacturing facility located at Mandva
  • Zydus receives final approval from the USFDA for Ivabradine Tablets, 5 mg and 7.5 mg
  • Eugia Pharma receives USFDA Approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampule
  • Aurobindo Pharma receives USFDA Approval for Darunavir Tablets, 600 mg and 800 mg
  • Lupin receives tentative approval from U.S. FDA for Canagliflozin Tablets
  • Lupin receives approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.07%
  • Strides receives USFDA approval for Generic Suprep® Bowel Prep Kit
  • Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta™ for ChemotherapyInduced Neutropenia
  • Lupin receives approval from U.S. FDA for Pitavastatin Tablets
  • Lupin receives tentative approval from U.S. FDA for Dapagliflozin Tablets
  • Strides receives USFDA approval for Levetiracetam Oral Solution
  • Lupin receives approval from U.S. FDA for Ganirelix Acetate Injection
  • Lupin receives tentative approval from U.S. FDA for Selexipag for Injection
  • NATCO Pharma announces successful completion of USFDA inspection
  • Lupin receives EIR from U.S. FDA for its Mandideep Unit-2 Manufacturing Facility
  • Natco Pharma Ltd receives 8 observations from USFDA for Pharma Division at Kothur
  • Granules India Ltd received ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules
  • Biocon Ltd - Update on U.S. FDA Inspection at Biocon Biologics' Manufacturing Facility in Johor, Malaysia
  • Glenmark Pharmaceuticals receives ANDA approval for Apremilast Tablets, 10 mg, 20 mg and 30 mg
  • Lupin receives tentative approval from U.S. FDA for Apalutamide Tablets
  • Lupin Receives Tentative Approval from U.S. FDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution
  • Dr. Reddy's Laboratories Ltd updates on USFDA PAI at its biologics facility
  • Zydus receives final approval from the USFDA for Sugammadex Injection, Single-Dose Vial

Latest Post

  • ReNew Signs MoU with Asian Development Bank for US$ 5.3 billion
  • Shree Ajit Pulp and Paper Ltd resumes production process at Unit I
  • Techknowgreen Solutions Ltd receives order worth Rs. 18 crores
  • Quess and NSDC Sign MoU to Enhance Skill Development and Employability
  • Tata Elxsi recognized as India's Top Value Creator for Software and BPM by Dun & Bradstreet


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2022